Latest BioPharma News and In-Depth Analysis | BioPharma BoardRoom

20 August, 2025 | Wednesday

23andMe Releases New Report Revealing Genetic Likelihood of Experiencing Panic Attacks

23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company, today released a new report as part of the 23andMe+ sub...

June 22, 2023 | Thursday | Reports

1
2
3
4
5
6
7
8
9
10

Partner Content

Thermo Fisher Launches Rapid CGP Solution on Genexus System to Advance Precision Oncology
15 July, 2025
Waters and BD Strike $17.5B Strategic Combination
15 July, 2025
Ultragenyx Receives Complete Response Letter from FDA for UX111 Gene Therapy for Sanfilippo Syndrome Type A
14 July, 2025
CARsgen Secures Final EPO Win for GPC3 CAR-T Patent After Appeal Withdrawal
14 July, 2025
iFIT and Samsung Health Partner to Redefine Connected Fitness and Personalised Healthcare Globally
14 July, 2025
EMA Lifts Age Restriction on Valneva’s Chikungunya Vaccine IXCHIQ® Following Safety Review
14 July, 2025
Golden Age Health and Innostellar Sign Exclusive 10-Year Deal to Deliver Sight-Saving Gene Therapy LX-101 Across China
14 July, 2025

BioPharma BreakThrough's

Editor Picks

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

Gene Editing Breakthroughs

Innovative Drug Discovery

Vaccine Development

Biologics and Therapeutic Antibodies

× Please select an option to participate in the poll.

View poll results More polls

× You have successfully cast your vote.

{{ optionDetail.option }} {{ optionDetail.percentage }}%

More polls

About Us Media Pack Contact Us Privacy Policy

© 2025 Biopharma Boardroom. All Rights Reserved.